MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
148 hedge funds and large institutions have $545M invested in Momenta Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
47% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 34
Holders
148
Holding in Top 10
–
Calls
$1.59M
Puts
$1.15M
Top Buyers
| 1 | +$7.64M | |
| 2 | +$6.08M | |
| 3 | +$4.52M | |
| 4 |
Renaissance Technologies
New York
|
+$4.42M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.95M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$8.06M | |
| 3 | -$5.79M | |
| 4 |
MHAM
Monroe Hall Asset Management
New York
|
-$5.45M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.7M |